Immune Checkpoint Inhibitors in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer

Overview of attention for article published in Current Treatment Options in Oncology, June 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
Average Attention Score compared to outputs of the same age and source

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 2,532 followers.

Immune Checkpoint Inhibitors in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer. https://t.co/UxTc5zJmdl

Review! Immune Checkpoint Inhibitors in Early-Stage & Locally Advanced Non-Small Cell #LungCancer https://t.co/oOPYSzmpE1

Immune Checkpoint Inhibitors in Early-Stage & Locally Advanced Non-Small Cell #LungCancer https://t.co/ft6SPI0VJC

Immune Checkpoint Inhibitors in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer. https://t.co/skIE8cdd7W https://t.co/QEoWITFkl9

Immune Checkpoint Inhibitors in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer. https://t.co/KHO4h85bTU